targeted-drug-delivery

Documents about targeted-drug-delivery

• Targeted drug delivery systems for cardiovascular disease treatment: principles, targeting strategies, and future prospects#253504Europe PMC
• Repurposing radiopharmaceutical carriers for targeted drug delivery and theranostics: A translational framework#202198Europe PMC
• Advancements in Cubosomes: A Promising Platform for Targeted Anticancer Drug Delivery#194517Indonesian Journal of Pharmacy
• Mitochondrial dysfunction and applications of mitochondrial-targeted delivery systems in atherosclerosis#4636Europe PMC
• AI -DRIVEN NANOMEDICINE FOR DRUG DELIVERY: INTERPLAY OF NANOCARRIER DESIGN, BIOLOGICALBARRIER AND THERAPEUTIC PERFORMANCE#181271Zenodo (CERN)
• Overcoming the Blood-Brain Barrier for Targeted Drug Delivery in Neurological Diseases#77767PhilArchive
• Toxicity of nanostructures in drug delivery applications#4483Europe PMC
• Development and Investigation of the Efficacy of Lapatinib Loaded Targeted Drug Delivery Nanosystem for Breast Cancer Treatment#195240İzmir Yüksek Teknoloji Enstitüsü
• Microalgae as novel drug-delivery system for biomedical field#4698Europe PMC
• Enhancement of drug delivery through fibroblast activation protein-targeted near-infrared photoimmunotherapy#292627OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Biodegradable Intra-arterial Devices for Focal Drug Delivery to Targeted Organs#441640bioRxiv / medRxiv
• NANOPARTICLES (NPS) BASED DRUG DELIVERY SYSTEM FOR CANCER THERAPY#458421Figshare
• Targeted proteoform degradation for precision drug design, delivery, and therapy.#174537NCBI PubMed Central
• Artificial Intelligence‐Driven Nanoarchitectonics for Smart Targeted Drug Delivery#478119CiNii
• Nano-formulation and controlled delivery of low solubility anticancer drugs#958026Louisiana Tech Digital Commons
• Brain-Targeted Delivery of Phenformin Using Phospholipid and Non-Phospholipid Vesicles for SHH Medulloblastoma#189728IRIS
• Extracellular vesicles in targeted drug delivery: from biological functions to surface engineering.#988387NCBI PubMed Central
• POLYSACCHARIDE-BASED TREATMENT APPROACHES FOR COLORECTAL CANCER#249182Zenodo (CERN)
• Stimuli-Responsive Peptides for Targeted Anticancer Drug Delivery: Current Advances and Future Outlook.#317885NCBI PubMed Central
• Implantable System for Remodulin Post-Approval Study#917905ClinicalTrials.gov
• Lipid-based nanoformulations in the treatment of neurological disorders#948630Repositorio de Universidad Autónoma de Chile.
• Coordination chemistry-enabled drug delivery systems: metal-ligand platforms for controlled release and targeted therapeutics.#472761NCBI PubMed Central
• The application of drug delivery systems based on targeted protein degradation chimeras in disease treatment strategies.#227957NCBI PubMed Central
• Combined Targeted Drug Delivery Systems for Mineral Metabolism Disorders in Chronic Kidney Disease: A Narrative Review.#613419NCBI PubMed Central
• Chitosan-based nanoparticles as a targeted drug delivery system to treat thyroid cancer: A literature review.#671005NCBI PubMed Central
• The reversed intra- and extracellular pH in tumors as a unified strategy to chemotherapeutic delivery using targeted nanocarriers#294469Gestión del Repositorio Documental de la Universidad de Salamanca
• Bio-magnetic nanomedicine for targeted drug delivery of breast cancer: green synthesis, functional design, and translational challenges.#258177NCBI PubMed Central
• BMBF-Förderprojekt "Nanofunktionale Hydrogele", Teilprojekt "Retina-Patch" : Schlussbericht#675000DataCite
• Overcoming the blood‒brain barrier: nanomedicine strategies for targeted delivery and multimodal therapy in Alzheimer's disease#4528Europe PMC
• Application of Halloysite Nanotubes in Bone Disease Remediation and Bone Regeneration#958448Louisiana Tech Digital Commons
• Photothermal and photodynamic therapy using nanomaterials for breast cancer#295614Recep Tayyip Erdoğan University Institutional Repository
• Therapeutic potential of antisense oligonucleotides in hematological malignancies#468233HAL (France)
• Biomimetic Nanoparticles: Novel Therapeutic Strategies for Autoimmune Diseases#256593İzmir Yüksek Teknoloji Enstitüsü
• MXene quantum dot polymer nanocomposites as smart platforms for targeted drug delivery and multifunctional biomedical applications: an updated review.#262962NCBI PubMed Central
• ACE2-PNA conjugates exploit viral endocytosis for targeted intracellular delivery and exhibit dual antiviral efficacy against SARS-CoV-2#651869Europe PMC
• Extracellular Vesicles Derived from Plasmodium-infected and Non-infected Red Blood Cells as Targeted Drug Delivery Vehicles#641680Dipòsit Digital de la Universitat de Barcelona
• Protective mechanisms and therapeutic promise of nanomaterials in radiation-induced diseases#996416Europe PMC
• Improving Site-Specific Antibody Conjugation to Liposomes Using Co-PoP and LASIC#207047ScholarlyCommons at Penn
• A Evaluation of the Safety of Oncocort IV Pegylated Liposomal Dexamethasone Phosphate in Patients With Progressive Multiple Myeloma#833373ClinicalTrials.gov
• Verbundprojekt: Nanofunktionale Hydrogele (NanoGel) - Teilvorhaben: Nanogele für gynäkologische Anwendungen : Schlussbericht ; Laufzeit des Vorhabens: 01.09.2005 - 31.12.2008#675041DataCite
• Intrathecal Ziconotide in Chemotherapy Induced Peripheral Neuropathy#917870ClinicalTrials.gov
• Cyano-modulated Zn(II)-Schiff base complexes for lysosome-targeted fluorescence imaging and pH-responsive camptothecin delivery#642284Europe PMC
• Visible-light-triggered halloysite nanotubes modified with Chlorin e6 and Polyethylene glycol–Folic Acid for site-specific chemo–photodynamic therapy#277411Repositorio UNAB
• Synthesis and design of biologically inspired biocompatible iron oxide nanoparticles for biomedical applications#954824Koc University Digital Collections
• Schlussbericht für das Verbundprojekt: Nanomagnetische Arzneistoffträger und eine integrierte Technologie für die therapeutische Anwendung : Teilvorhaben: Zell-Transfektion, Targeting und Positionierung von Nanopartikel-markierten Wirkstoffen durch statische und dynamische Magnetfelder#319941DataCite
• NanoMagnetoStent - Behandlung von Gefäßstenosen und -Restenosen durch steuerbare Rapamycindeposition mittels magnetisierbarer Microbubbles, Teilvorhaben: Formulierungen magnetischer Rapamycin-Nanopartikel für die Wiederbeladung von magnetisierbaren Stents : Schlussbericht ; Laufzeit des Vorhabens: 01.02.2007 - 31.07.2008#675048DataCite